Activation of IGF1R confers acquired resistance to osimertinib in EGFR-mutant NSCLC with T790M mutation

Publication Name : CANCER SCIENCE 113, 1060-1060, 2022

Citation :

Date : 2022

Publication URL

https://scholar.google.com/scholar?q=+intitle:"Activation of IGF1R confers acquired resistance to osimertinib in EGFR-mutant NSCLC with T790M mutation"

Authors

WIRA WINARDI

S1 - Pendidikan Dokter

Files